Skip to main content
Clinical Trials/DRKS00019096
DRKS00019096
Completed
Not Applicable

Evaluation of the acute- and long-term results after endovascular therapy of the popliteal artery

niversitäts-Herzzentrum Bad Krozingen0 sites378 target enrollmentNovember 8, 2019
ConditionsI70.22

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
I70.22
Sponsor
niversitäts-Herzzentrum Bad Krozingen
Enrollment
378
Status
Completed
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
November 8, 2019
End Date
October 1, 2019
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Sponsor
niversitäts-Herzzentrum Bad Krozingen

Eligibility Criteria

Inclusion Criteria

  • Patients with peripheral arterial occlusive disease in clinical stage 1\-3 according to Rutherford\-Becker classification.
  • \- De\-novo stenosis caused by arteriosclerotic disease (\=70% diameter reduction) or occlusion of the popliteal artery, duplex sonographically and/or angiographically confirmed.
  • \- Stenosis or occlusion of the popliteal artery which not include the superficial femoral artery and/or the anterior tibial artery and/or the tibiofibular truncus.
  • \- At least one open, non\-stenosed (\=50% diameter reduction) lower leg artery on the study leg.
  • \- At least one follow\-up examination (including duplex sonography) in a period of at least 12 months after the index procedure.

Exclusion Criteria

  • \- Patients with PAD in stage 0, 4 \- 6 according to Rutherford\-Becker classification.
  • \- Stenosis or occlusion of the poplitea artery not due to arteriosclerotic causes.
  • \- No relevant stenosis of the target lesion (\<70% diameter reduction).
  • \- Ectasia or aneurysm of the poplitea artery (target lesion diameter \>7mm)
  • \- Unsuccessful intervention of the target lesion (remaining residual stenosis \=30%)
  • \- Re\-stenosis or re\-occlusion of the target lesion after previous surgical and/or endovascular therapy.
  • \- Treated target lesion of the poplitea artery extends to the superficial femoral artery and/or the antior tibial artery and/or the tibiofibular truncus.
  • \- Occlusion or relevant stenosis (\>50% diameter reduction) of all lower leg arteries.
  • \- Limited renal function (creatinine \=2\.4mg/dl) or terminal renal insufficiency requiring dialysis during index procedure.
  • \- No follow\-up imaging (duplex sonography or angiography) of the target lesion at least 12 months after the index procedure (lost\-to\-follow\-up).

Outcomes

Primary Outcomes

Not specified

Similar Trials